Therapy News and Research

RSS

Researchers publish microbial profile to support growing field of gut research

There are 157 organisms that form the baseline biome of a healthy human gut, according to research published in the journal PLOS ONE by investigators at the George Washington University.

12 Sep 2019

Scientists attempt to cure HIV using CRISPR, with varying results

Scientists have used the gene-editing technology CRISPR in an attempt to cure a person infected with HIV, with some success.

12 Sep 2019

Scientists use CAR-T cells to reverse cardiac fibrosis

Scientists have used CAR-T cell therapy to treat cardiac fibrosis, a key part of heart disease and cardiac arrest.

12 Sep 2019

Engaging community pharmacists to improve access to care for people with epilepsy

The University of Washington's School of Pharmacy announced on Thursday, Sept. 12, a collaboration with global biopharmaceutical company UCB to improve access to care for people living with epilepsy.

12 Sep 2019

New approach enables the body to produce specific antibodies

Researchers at KU Leuven in Belgium have developed a technique to make sheep produce new antibodies simply by injecting the DNA building blocks.

12 Sep 2019

ECLS trial demonstrates potential of blood test for early lung cancer detection

Oncimmune Holdings plc, a leading global immunodiagnostics group, welcomes the presentation of data today by Professor Frank Sullivan (Chief Investigator on the ECLS trial) which has demonstrated the potential of Oncimmune’s EarlyCDT Lung test to reduce the incidence of patients with late-stage lung cancer at diagnosis, compared with standard clinical diagnosis.

12 Sep 2019

Asia-Pacific’s eminent minds to showcase latest breakthroughs in stroke research

More than 450 of the Asia-Pacific’s eminent minds in stroke will converge on Canberra this week to showcase the latest breakthroughs in research contributing to our understanding of stroke.

12 Sep 2019

BIA Separations launches Cornerstone AAV Process Development Service to improve gene therapy production

BIA Separations, a leading bio-chromatography development and manufacturing company, today announced the introduction of CORNERSTONE AAV Process Development Service, a program of integrated process development services and novel technology designed to improve the robustness and yield of AAV-based gene therapy production, while improving the safety of therapeutic products.

12 Sep 2019

Cancer disease incidence and severity influenced by gene mutation, tissue location

The KRAS gene is one of the commonly mutated genes in cancer. More than 40 percent of colorectal cancers have a mutated KRAS gene, or oncogene, that is at least partially responsible for cancer development.

12 Sep 2019

Malarial treatment from Antarctic sea sponge

Malaria, which ravages hot tropical areas, could be treated effectively using a protein extracted from an Antarctic sponge.

12 Sep 2019

Simple genetic test may boost response rates in children with eosinophilic esophagitis

Personalized medicine - where the proper medicine and proper dose are used for the individual patient - moved a step closer to reality for children suffering from eosinophilic esophagitis, an inflammation of the food pipe often caused by an allergic reaction to certain foods.

12 Sep 2019

CAR T-cell therapy may be viable treatment option for heart disease

CAR T-cell therapy, a rapidly emerging form of immunotherapy using patients' own cells to treat certain types of cancers, may be a viable treatment option for another life-threatening condition: heart disease.

12 Sep 2019

Gene coding error likely responsible for rare form of inherited 'short telomere' disease

By combing through the entire genetic sequences of a person with a lung scarring disease and 13 of the person’s relatives, Johns Hopkins Medicine researchers say they have found a coding error in a single gene that is likely responsible for a rare form of the disease and the abnormally short protective DNA caps on chromosomes long associated with it.

From Johns Hopkins Medicine 11 Sep 2019

Gyros Protein Technologies launches Gyrolab p24 Kit for scientists in cell and gene therapy market

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced the introduction of Gyrolab® p24 Kit, for lentivirus titer determination in lentivirus vector manufacturing.

From Gyros Protein Technologies AB 11 Sep 2019

Oxford Genetics unveils OXGENE brand

Oxford Genetics Ltd announces the launch of its brand OXGENE™. The new brand articulates the company’s powerful ability to combine highly innovative science with an engineering approach to custom solutions for biotechnology.

From OXGENE 11 Sep 2019

Scientists find a link between brain’s emotion circuit and movement

The brain is a powerful organ that controls all the body processes, including movement. In some athletes, however, they usually experience a phenomenon called “choking,” wherein their performance rapidly declines when they’re under a lot of pressure.

11 Sep 2019

FAU physician secures ERC Starting Grant of 1.5 million euros for cutting-edge research

Physician Dr. Andreas Ramming from Friedrich-Alexander-Universität Erlangen-Nürnberg has succeeded in securing research funding in one of the toughest European selection processes.

10 Sep 2019

Long-term antibiotic use in preemies promotes drug-resistant gut bacteria

Very preterm infants are often sick and require antibiotic treatment to save their lives. However, when this form of therapy lasts for 20 months or more, it may affect the gut microbiome over the long-term in addition to its acute effects.

10 Sep 2019

Scientists unveil key brain cells that suppress drug cravings

Illicit drug use has been linked to disability, death, and the risk for many diseases. But more, it is associated with risks to the person’s family, friends, and the community.

10 Sep 2019

Gut microbiome and IBD – the connection maybe in diet says study

A new study has shown conclusive evidence that inflammatory bowel disease or IBD is intimately associated with the gut microbial environment which can be altered with prescription diet. The microbiome within the human gut is a collection of healthy and helpful bacteria that help in several functions of the body including development and maintenance of immunity.

10 Sep 2019

Therapy News and Research

Researchers publish microbial profile to support growing field of gut research

Scientists attempt to cure HIV using CRISPR, with varying results

Scientists use CAR-T cells to reverse cardiac fibrosis

Engaging community pharmacists to improve access to care for people with epilepsy

New approach enables the body to produce specific antibodies

ECLS trial demonstrates potential of blood test for early lung cancer detection

Asia-Pacific’s eminent minds to showcase latest breakthroughs in stroke research

BIA Separations launches Cornerstone AAV Process Development Service to improve gene therapy production

Cancer disease incidence and severity influenced by gene mutation, tissue location

Malarial treatment from Antarctic sea sponge

Simple genetic test may boost response rates in children with eosinophilic esophagitis

CAR T-cell therapy may be viable treatment option for heart disease

Gene coding error likely responsible for rare form of inherited 'short telomere' disease

Gyros Protein Technologies launches Gyrolab p24 Kit for scientists in cell and gene therapy market

Oxford Genetics unveils OXGENE brand

Scientists find a link between brain’s emotion circuit and movement

FAU physician secures ERC Starting Grant of 1.5 million euros for cutting-edge research

Long-term antibiotic use in preemies promotes drug-resistant gut bacteria

Scientists unveil key brain cells that suppress drug cravings

Gut microbiome and IBD – the connection maybe in diet says study

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News